FECH and cancer: Unexpectedly, the ferrochelatase (FECH) gene encoding FECH that catalyzes the final critical step of heme biosynthesis is dispensable in several cancers, suggesting that cancer cell lines are capable of bypassing endogenous biosynthesis of heme in vitro, yet are still dependent on genes encoding enzymes that mediate intermediate steps of heme biosynthesis.